Clinical Trials Browser

Unknown × relmacabtagene autoleucel × Clear all

NCT05590221 2024-01-08

Relmacabtagene Autoleucel as First-Line Therapy for High-Risk Large B-Cell Lymphoma

Phase 2 Unknown

Lymphoma, B-Cell

NCT03355859 2019-07-12

Study Evaluating the Safety and Efficacy of JWCAR029 in Adult Subjects With Relapsed and Refractory B-cell Non-Hodgkin Lymphoma

Phase 1 Unknown

Lymphoma, Non-Hodgkin